Ctrl

K

Nepafenac

Class
Nonsteroidal anti-inflammatory drugs
Subclass
Acetates
Generic name
Nepafenac
Brand names
Ilevro®
Common formulations
Ophthalmic suspension
Dosage and administration
Adults patients
Treatment of postoperative ocular inflammation and pain, after ocular surgery
•
1 gtt OPHTH daily first 2 weeks of the postoperative period
Indications for use
Labeled indications
Adults
•
Treatment of postoperative ocular inflammation and pain, after ocular surgery
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
•
Use only if benefits outweigh potential risks. Evidence of fetal harm in animals.
Breastfeeding
Acceptable for use during breastfeeding.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Common 1-10%
•
Conjunctival injection, corneal edema, ↓ visual acuity, dry eye disease, hypertension, ↑ intraocular pressure, posterior vitreous detachment, eye discharge, eye pain, foreign body sensation in the eyes, headache, itchy eyes, nausea, tearing, visual disturbances, vomiting, sinusitis
Unknown frequency
•
Corneal erosion, corneal thinning, corneal ulcers, delayed wound healing, hyphema, keratitis, ocular hemorrhage, photophobia, retinal perforations
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource